Jul 17 2024

Study Finds Marijuana May Reduce Gastrointestinal Symptoms

A new study has found that marijuana significantly reduces the severity of gastrointestinal symptoms in patients.

The study, titled Relief in Gastrointestinal Symptoms with Medical Marijuana Over 1 Year, was published in the journal Medical Cannabis and Cannabinoids, and it was published online by the US National Library of Medicine. Researchers say this “is the first study to examine MMJ’s [medical marijuana’s] longitudinal effects on GI symptoms in patients with refractory GI and non-GI MMJ-certified conditions.”

Participants in the study completed surveys at four intervals: at the start of the study, after 30 days, at six months, and at 12 months. They rated the severity of their GI symptoms on a scale from 1 (mild) to 3 (severe).
Continue reading

Jul 17 2024

Majority Want the DEA to Deschedule Rather than Reschedule Marijuana

There have been over 31,000 comments submitted on the DEA’s proposal to reschedule marijuana.

Since the DEA published their proposal in the Federal Register on May 21, there have been 31,400 comments submitted. The comment period ends on July 22.

Of the over 30,000 comments—all of which can be viewed by clicking here—a slight majority (51%) are calling on the DEA to go even further than their plan to move marijuana to Schedule III and instead deschedule it entirely. When including comments urging the government to decriminalize or legalize marijuana, the number rises to over 70%.
Continue reading

Jul 17 2024

Kentucky Governor Sends Letter to DEA in Support of Marijuana Rescheduling

In a letter to DEA Administrator Anne Milgram, Governor Andy Beshear endorsed the proposal to reschedule marijuana from Schedule I to Schedule III under the Controlled Substances Act.

“As governor, my job is to move our state forward,” said Beshear. “Rescheduling marijuana to Schedule III is a significant, common-sense step forward for all Kentuckians, especially those with significant medical conditions.”

The Governor wrote that the step would help patients have an alternative to deadly opioids and continued access to safe products and help communities further reduce crime and illicit drug use. “Rescheduling would also create fair markets by placing cannabis businesses on the same economic footing as any other business and provide real opportunities for research on marijuana”, states the letter.
Continue reading

Jul 16 2024

President Joe Biden Tells NAACP He’s “Making Sure” People Aren’t Jailed for Marijuana, Calls for Charges to be Expunged

President Joe Biden told members of the NAACP today that he’s “making sure” that no one is jailed anymore for possessing or using marijuana.

“By the way, we’re making sure that no one goes to jail for the mere use or possession of marijuana,” said Biden at the115th NAACP National Convention . “Their records should be expunged – it holds them back.”

The comments come with less than a week remaining for the public comment period on the DEA’s proposal to reschedule marijuana to Schedule III, the first federal marijuana law change since the Controlled Substances Act was enacted in 1970. The move would not legalize recreational marijuana, but it would allow marijuana compounds and medicines made from them to be prescribed nationwide, if they receive regulatory approval.
Continue reading

Jul 16 2024

Bipartisan and Bicameral Federal Legislation to Allow Marijuana Banking Now Has 165 Sponsors

The push for federal legislation to enable marijuana banking has gained substantial momentum, now boasting a combined total of 165 bipartisan sponsors across both chambers of Congress.

In the House of Representatives, the SAFE Banking Act (H.R. 2891) has 128 sponsors, comprising 101 Democrats and 27 Republicans, making it the most supported marijuana-related bill in Congress. The bill aims to provide explicit federal protections for banks and credit unions that offer financial services to state-legal marijuana businesses. These businesses include medical marijuana dispensaries in 38 states and recreational marijuana stores in 23 states.

On the Senate side, the SAFER Banking Act (S.2860) now has 37 sponsors following Senator Lisa Murkowski’s (R-AK) recent endorsement. Murkowski, the fifth Republican to back the bill, became the 37th sponsor. This measure similarly aims to shield financial institutions from federal penalties when servicing state-legal marijuana enterprises. The Senate Banking Committee approved the SAFER Banking Act with bipartisan support in September, shortly after it was introduced. Senate Majority Leader Chuck Schumer has committed to bringing the measure to a full Senate vote soon, though no specific date has been set.
Continue reading

Jul 15 2024

Trump Selects Ohio Senator J.D. Vance as Vice Presidential Candidate: Where He Stands on Marijuana Reform

Former President Donald Trump has chosen Ohio Senator J.D. Vance as his vice president running mate for the 2024 presidential election.

Trump announced the choice today at the Republican National Convention. J.D. Vance, a Republican known for his conservative values, has shown skepticism about fully legalizing marijuana at the federal level, citing concerns about potential societal impacts and the need for careful consideration to avoid unintended consequences. This aligns with his general conservative stance on drug policy in general.

On the matter of the SAFER Banking Act, which would allow banks to provide services to state-legal marijuana businesses, Vance has shown some openness to it, but voted against advancing the bill in the Senate Banking Committee in September, “due to several public safety-related concerns.” He has also indicated that the upsides of the SAFER Banking Act are “overstated”, and said “I am worried that this could open the door for other illicit activities, like the trafficking of fentanyl and methamphetamines, to access depository insurance.”
Continue reading

Jul 15 2024

New Study Finds CBD Oil Improves Symptoms in Children with Moderate to Severe Autism

A new study published in the journal Pharmaceuticals has found that high-CBD, full-spectrum cannabis extract can improve the symptoms of moderate to severe non-syndromic Autism Spectrum Disorder (ASD) in children and adolescents.

The study, titled “Clinical and Family Implications of Cannabidiol (CBD)-Dominant Full-Spectrum Phytocannabinoid Extract in Children and Adolescents with Moderate to Severe Non-Syndromic Autism Spectrum Disorder (ASD): An Observational Study on Neurobehavioral Management,” demonstrates significant improvements in both core and comorbid symptoms of ASD.

The research team, consisting of researchers from the University of Brasilia and the University Hospital of Brasilia, conducted a retrospective, observational, and cross-sectional cohort study involving 30 participants aged 5 to 18. The participants were treated with individualized doses of a CBD-dominant extract containing a CBD to THC ratio of 33:1. Neuropsychological evaluations and clinical assessments were performed, and parents or caregivers were independently interviewed to gauge perceived treatment effects.
Continue reading

Jul 15 2024

It’s the Final Week to Submit Comments on the DEA’s Marijuana Rescheduling Proposal

There’s now just one week remaining in the legally required 60-day public comment period regarding the Drug Enforcement Administration’s (DEA) proposal to reschedule marijuana.

The DEA published their proposal in the Federal Register on May 21, which officially launched the public comment period. There is now just seven days remaining before the comment period closes on July 22. All comments to the DEA are publicly accessible and can be viewed by clicking here, and those interested can submit their own comment by clicking here.

Currently there have been 30.5k comments submitted. An analysis of the submitted comments shows that over 50% want the DEA to fully deschedule marijuana. When you add those who call on the DEA to legalize or decriminalize marijuana, this jumps to above 70%. A shockingly low 8% of comments are urging the DEA to reject their own proposal plus any additional changes to instead keep marijuana as a Schedule I drug.
Continue reading

Jul 15 2024

June Marijuana Sales in Rhode Island Reach $9.68 Million, Boosting 2024 Total to Over $58 Million

In June, Rhode Island’s marijuana sales continued to climb, reaching $9.68 million, a slight increase from the $9.16 million recorded in June of the previous year.

According to the Rhode Island Department of Business Regulations, June’s sales included $7.65 million from recreational marijuana and $2.03 million from medical marijuana. The average transaction amount for June was $37.13.

This brings the total sales for 2024 to $58,565,192. Last year, the total sales amounted to $107,816,615, contributing approximately $15 million in tax revenue.
Continue reading

Jul 14 2024

Every Marijuana Bill Currently Alive in the US Congress

Here’s an overview of all the marijuana-related bills currently under consideration in the United States Congress.

Per congressional rules, any marijuana-related bill introduced before January 2023 is now inactive. Bills filed on or after January 2023 will become inactive (if not enacted into law) before the next legislative session in January 2025. Legislators have the option to reintroduce any inactive bill if they choose to do so.

At present, there are 21 active marijuana-related bills, with varying levels of support and progress. Below is a look at each of these measures.
Continue reading